Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2
2021 2
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
In Silico Engineering of Enzyme Access Tunnels.
Gautieri A, Rigoldi F, Torretta A, Redaelli A, Parisini E. Gautieri A, et al. Among authors: torretta a. Methods Mol Biol. 2022;2397:203-225. doi: 10.1007/978-1-0716-1826-4_11. Methods Mol Biol. 2022. PMID: 34813066
New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action.
Luque-Navarro PM, Carrasco-Jiménez MP, Goracci L, Paredes JM, Espinar-Barranco L, Valverde-Pozo J, Torretta A, Parisini E, Mariotto E, Marchioro C, Laso A, Marco C, Viola G, Lanari D, López Cara LC. Luque-Navarro PM, et al. Among authors: torretta a. Eur J Med Chem. 2023 Jan 15;246:115003. doi: 10.1016/j.ejmech.2022.115003. Epub 2022 Dec 5. Eur J Med Chem. 2023. PMID: 36493617
Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors.
Luque-Navarro PM, Mariotto E, Ballarotto M, Rubbini G, Aguilar-Troyano FJ, Fasiolo A, Torretta A, Parisini E, Macchiarulo A, Laso A, Marco C, Viola G, Carrasco-Jimenez MP, López-Cara LC. Luque-Navarro PM, et al. Among authors: torretta a. Pharmaceutics. 2022 Mar 27;14(4):715. doi: 10.3390/pharmaceutics14040715. Pharmaceutics. 2022. PMID: 35456549 Free PMC article.
New Compounds with Bioisosteric Replacement of Classic Choline Kinase Inhibitors Show Potent Antiplasmodial Activity.
Aguilar-Troyano FJ, Torretta A, Rubbini G, Fasiolo A, Luque-Navarro PM, Carrasco-Jimenez MP, Pérez-Moreno G, Bosch-Navarrete C, González-Pacanowska D, Parisini E, Lopez-Cara LC. Aguilar-Troyano FJ, et al. Among authors: torretta a. Pharmaceutics. 2021 Nov 2;13(11):1842. doi: 10.3390/pharmaceutics13111842. Pharmaceutics. 2021. PMID: 34834257 Free PMC article.
Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines.
García-Molina P, Sola-Leyva A, Luque-Navarro PM, Laso A, Ríos-Marco P, Ríos A, Lanari D, Torretta A, Parisini E, López-Cara LC, Marco C, Carrasco-Jiménez MP. García-Molina P, et al. Among authors: torretta a. Pharmaceutics. 2022 Feb 16;14(2):426. doi: 10.3390/pharmaceutics14020426. Pharmaceutics. 2022. PMID: 35214160 Free PMC article.
11 results